Excessive haemorrhage associated with caesarean section, commonly defined as blood loss in excess of 1000 ml, is frequently underestimated, but is documented as occurring in more than 5-10% of caesarean sections. Common causes are uterine atony, abnormal placentation, uterine trauma and sepsis. It is a major cause of maternal morbidity globally and of maternal mortality in low- and middle-income countries; however, many reports do not disaggregate it from postpartum haemorrhage in general. In this chapter, we outline preventive measures, including uterotonic agents, and provide treatment algorithms for managing excessive haemorrhage during and after caesarean section. Several management options, including uterotonic therapy, uterine compression sutures, balloon tamponade, blood-vessel ligation and uterine artery embolisation are described; each has a role for treating the different causes of caesarean section bleeding in different contexts. Caesarean hysterectomy is indicated when medical and conservative surgical measures are unsuccessful, and as first-line surgery for extensive uterine rupture and bleeding from morbidly adherent placentae. It has an incidence ranging from 1-4 per 1000 caesarean sections, significantly greater than that for vaginal delivery. Although it is a life-saving procedure, it is associated with significant morbidity, including massive blood transfusion and intensive care (10-48%), urological injury (8%) and the need for relook laparotomy (8-18%).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bpobgyn.2012.08.018 | DOI Listing |
Introduction: Dengue is a mosquito-borne viral disease. It has been associated with high maternal and foetal morbidity and mortality. Therefore, this study aimed to describe the outcomes of Dengue infection in pregnant women in terms of maternal bleeding, miscarriage, preterm delivery, severe Dengue, Dengue shock and maternal mortality, as well as foetal outcomes in terms of foetal distress, low birth weight and neonatal mortality.
View Article and Find Full Text PDFCureus
March 2025
Department of Midwifery, Faculty of Health and Caring Sciences, University of West Attica, Athens, GRC.
Artificial intelligence (AI) and machine learning (ML) are rapidly evolving technologies with significant implications in obstetrics and midwifery. This systematic review aims to evaluate the latest advancements in AI and ML applications in obstetrics and midwifery. A search was conducted in three electronic databases (PubMed, Scopus, and Web of Science) for studies published between January 1, 2022, and February 20, 2025, using keywords related to AI, ML, obstetrics, and midwifery.
View Article and Find Full Text PDFGinekol Pol
March 2025
Department of Obstetrics and Gynecology, Okan University School of Medicine, Istanbul, Türkiye.
Objectives: The aim was to construct a reliable working model for patients with placenta previa (PP) that aids in the prediction of postpartum bleeding potential with data from antenatal imaging studies using both ultrasound (US) and magnetic resonance imaging (MRI).
Material And Methods: Forty-three patients with PP were evaluated initially with the US and then by 3-Tesla MRI. The Placenta Accreata Index (PAI) was used during the US evaluation in order to define the risks.
Ann Afr Med
March 2025
Department of Obstetrics and Gynecology, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.
Background: Preventing postpartum haemorrhage (PPH) is a significant concern because of its effect on maternal morbidity and mortality. PPH is leading cause of maternal death in developing countries and also globally.
Aim: Evaluation of safety and efficacy of carbetocin versus oxytocin for PPH prevention in caesarean deliveries.
BMC Pregnancy Childbirth
March 2025
Department of Obstetrics and Gynecology, Faculty of Medicine, Hadassah University Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
Background: The age at first delivery is rising leading to an increasing proportion of women with advanced maternal age (AMA) which is defined as greater than or equal to 35 years at time of delivery. Previous studies have associated AMA with adverse maternal and neonatal outcomes leading to an arbitrary increased rate of cesarean sections amongst AMA women without clear medical indications.
Objective: To determine the associations between AMA and adverse maternal and neonatal outcomes in nulliparous women in a large cohort.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!